Device Cardiopulmonary

Vitalflow Console

Payments companies reported to CMS as associated with Vitalflow Console. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$67Kassociated payments (2023-2025)
305clinicians with associated payments
1company reporting

By year

2024 $676
2025 $67K

Payments reported as associated with Vitalflow Console, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anesthesiology $20K
Surgical Critical Care $8,333
Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,950
Pediatric Critical Care Medicine $5,965
Critical Care Medicine (Internal Medicine) $2,502
Hospitalist $2,483

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vitalflow Console

These are the largest totals companies reported as associated with Vitalflow Console. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rafal Kopanczyk Columbus, OH Anesthesiology $19,026.10
David Shapiro Hartford, CT Surgical Critical Care $4,750.00
Harry Kallas Fresno, CA Pediatric Critical Care Medicine $2,519.74
Nataly Shildt Atlanta, GA Hospitalist $2,414.14
Melissa Brunsvold Minneapolis, MN Surgical Critical Care $1,814.58
Kendall Mceachron Minneapolis, MN Surgical Critical Care $1,743.62
Gwenyth Fischer Minneapolis, MN Pediatric Critical Care Medicine $1,714.83
Matthew Orlowski San Francisco, CA Critical Care Medicine (Anesthesiology) $1,604.58
Jason Gluck Hartford, CT Advanced Heart Failure and Transplant Cardiology $1,577.18
Antonio Panza Cincinnati, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,576.42

Prescribed Vitalflow Console?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.